Marcucci G et al showed differential prognostic impact of different types of DNMT3A mutations in older vs younger patients: R882 mutations are associated with adverse prognosis in older patients whereas non–R882 mutations are associated with adverse prognosis in younger CN-AML [47]. Here, DNMT3A is linked to acute myeloid leukemia.